Could GLP-1s kill plus size fashion? - Reuters
rss:reuters-gnews 10d ago
Danish study finds workers taking GLP-1 medications experienced 17% fewer long-term sick leave absences. The finding suggests weight-loss drugs may improve workplace attendance and employee health outcomes.
Rod Wave Says Boosie “Broke My Heart” Over Sampling Dispute, But Boosie Says He’s “Playing Victim” https:// balleralert.com/rod-wave-boosi e-playing-victim-sampling-feud/?utm_source=dlvr.it&utm_medium=mastodon
GLP-1 medications, originally developed for diabetes, are now widely used for obesity treatment and significantly reshaping the US healthcare system. The drugs' expanded adoption raises questions about accessibility and whether all populations should use them.
Compounded versions of GLP-1 drugs, including cheaper alternatives to Ozempic, are raising concerns among doctors and the FDA due to serious safety risks. While more accessible and affordable than brand-name medications, these compounded drugs lack equivalent regulatory oversight.
More than 90 lawsuits against GLP-1 companies claim rare eye condition resulted from diabetes and weight loss drugs.
GLP-1s Are Being Linked to Fewer Serious Infections, Including TB. com/ozempic-and-other- glp-1s-are-being-linked-to-fewer-serious-infections-including-tb-2000806796 C: https:// new.
A new study found that GLP-1 weight loss drugs including Mounjaro, Ozempic, and Wegovy are linked to increased risk of hair loss, though the absolute risk remains low. The risk of alopecia for GLP-1 users is significantly higher than for people taking other diabetes medications.
Illinois Gov. JB Pritzker sat down with David Begnaud to talk about something he's never shared before: his GLP-1 weight loss journey.
¡No te rindas!
As social media becomes saturated with before-and-after weight-loss content and aggressive GLP-1 drug marketing, individuals struggle to maintain positive body image and self-acceptance. Cultural pressure around pharmaceutical weight loss is reshaping attitudes toward body diversity.
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs, which have proven effective in treating obesity and diabetes, may also be useful in treating addiction.
Hayes, J. (2026).
Millions take GLP-1 drugs for diabetes and obesity, but do they affect mental health? 🧠 Latest review finds no clear psychiatric risk - yet one obesity study raises new questions.
PSA. Science Daily: Large Study Shows More REM sleep linked to lower risk of 83 diseases https://www.
Boghog: Normalized citation templates
I definitely get the desire and to not have to pay the huge cost. org/petitions/b5...
This cluster contains disparate fragments: a Japanese fashion collaboration announcement (Y's and FAF), a Greek-language post about GLP-1 weight-loss drugs versus bariatric surgery, a notice of ancestral remains found in Kamloops, a Windows notification joke, and a post celebrating finding a yogurt spoon.
The authors included RRIDs in their in Journal of Cell Science paper! RRIDs improve reproducibility in scientific research.